{'fraction_non_alphanumeric': 0.028688524590163935, 'fraction_numerical': 0.00819672131147541, 'mean_word_length': 4.850299401197605, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The use of hydroxyurea to study the proliferative state of T-cell precursors (CFUT) in murine bone marrow.

The cycle specific drug, hydroxyurea (HU), has previously been used to study the proliferative kinetics of various hemopoietic precursor cells such as granulocyte-macrophage precursors (CFUc) and multipotential stem cells (CFUs). We have investigated the kinetics of another hemopoietic precursor, a T-cell colony (CFUT). When mice are exposed to two doses of HU, separated by 7 h, CFUT are reduced to approximately 30% of the control value. Surviving cells in the bone marrow quickly replenish the population and return it to normal values 2 days after HU treatment. When fresh bone marrow cells or bone marrow cells harvested from mice exposed 24 h earlier to HU are treated in vitro with HU, CFUT activity is reduced by approximately 70%. These data indicate that CFUT is a rapidly proliferating population with a large proportion of the cells always in cell cycle.